Sánchez-Sanz, Alicia
Posada-Ayala, María
Sabín-Muñoz, Julia
Fernández-Miranda, Ismael
Aladro-Benito, Yolanda
Álvarez-Lafuente, Roberto
Royuela, Ana
García-Hernández, Ruth
la Fuente, Ofir Rodríguez-De
Romero, Julián
García-Merino, Antonio
Sánchez-López, Antonio José
Funding for this research was provided by:
Instituto de Salud Carlos III (FI19/00149)
Ministerio de Ciencia e Innovación (PID2019-108992RB-I00)
Article History
Received: 18 November 2021
Accepted: 4 October 2022
First Online: 24 November 2022
Competing interests
: AS, IF, RA, AR, OR and AJS have nothing to disclose. MP and JR have received funding from GW Pharmaceuticals and Medicane Ltd. JS has received funding for research projects and conference fees, mentoring, and assistance for conference attendance from Teva, Merck, Biogen, Roche, Novartis, and Sanofi. YA has received funding for research projects and conference fees, mentoring, and assistance for conference attendance from Teva, Merck, Biogen, Roche, Novartis, Allmirall and Sanofi. RG has received compensation for travel expenses from Novartis, Merck and Sanofi-Genzyme. AG has received compensation for travel expenses, speaking honoraria and consultation fees from Bayer, Merck, Teva, Biogen Idec, Novartis, Roche, Almirall and Sanofi-Genzyme.